CN1390600A - Medicine for treating gastritis and gastric or duodenal ulcer and its preparing process - Google Patents
Medicine for treating gastritis and gastric or duodenal ulcer and its preparing process Download PDFInfo
- Publication number
- CN1390600A CN1390600A CN02138008A CN02138008A CN1390600A CN 1390600 A CN1390600 A CN 1390600A CN 02138008 A CN02138008 A CN 02138008A CN 02138008 A CN02138008 A CN 02138008A CN 1390600 A CN1390600 A CN 1390600A
- Authority
- CN
- China
- Prior art keywords
- rhizoma
- medicine
- crushed
- orders
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine for treating gastritis and gastric or duodenal ulcer is prepared from 7 Chinese-medicinal materials including notoginseng, coptis root, bletilla tuber, corydalis tuber, etc through proportional mixing, pulverizing, sterilizing at 110 deg.C for 30 min, and shaping. Its advantages are high curative effect and cure rate, durable act, and no toxic by-effect.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of gastritis, stomach, duodenal ulcer, is that raw material is through processing, be refined into Chinese patent medicine with pure Chinese herbal medicine specifically.The invention still further relates to the preparation method of this medicine.
Background technology
For a long time, the harm people's that gastritis, stomach, duodenal ulcer are serious health, this type of disease sickness rate is high and be distributed among the crowd widely.
At present, various to this type of treatment of diseases medicament categories both at home and abroad, its treatment characteristic has nothing in common with each other, but real evident in efficacy and the treating both the principal and secondary aspects of a disease person is very few.As present clinical quite a few medicine that is used for the treatment of, only with single mechanism of action control and treatment disease: antacid class medicine only reaches the purpose of pain relieving and relief of symptoms with the antacid effect; Spasmolytic class medicine only reaches the purpose of pain relieving and relief of symptoms with spasmolysis.And all can not promote wound healing, reconcile gastrointestinal function.
Summary of the invention
The object of the present invention is to provide that a kind of function is complete, good effect, cure rate height, hold the Chinese patent medicine of the treatment gastritis of imitating long and nontoxic, side effect, stomach, duodenal ulcer.
Another object of the present invention provides the preparation method of the medicine of this gastritis, stomach, duodenal ulcer.
Solution of the present invention is based on motherland's Chinese medicine, by the selected all medicines of " interior warp " theoretical " five ZANG-organs and six FU-organs all obtaining QI from the stomach " " the strongly fragrant people's disease of sending out of wood is taken care and pain in gastral cavilty ", general character according to multiple disease is deliberated repeatedly, meticulous effect, make product of the present invention, its drug effect reaches fully gives inner feelings at the beginning of the phase solution, be blood circulation promoting and blood stasis dispelling, regulating QI to relieve pain, antacid convergence, the healing ulcer surface, repair gastric mucosa, and the pathogenic heat of more clearing up and discharging, ascending healthy energy, help transporting and transforming function of the spleen and stomach, auxiliary effect such as dispersing the stagnated live-QI to relieve the stagnation of QI.
Medicine of the present invention is made by following component: (consumption is a weight portion)
Radix Notoginseng 8-28 Rhizoma Coptidis 4-25 Pseudobulbus Bletillae (Rhizoma Bletillae) 10-40 Rhizoma Corydalis 15-50
Radix Et Rhizoma Rhei 8-45 Concha Arcae 15-30 Endoconcha Sepiae 8-25
The optimum weight of medicine of the present invention (part) proportioning is:
Radix Notoginseng 11 Rhizoma Coptidis 8.5 Pseudobulbus Bletillae (Rhizoma Bletillae)s 35 Rhizoma Corydalis 29
Radix Et Rhizoma Rhei 14.5 Concha Arcaes 20.4 Endoconcha Sepiaes 17
Above-mentioned each component is made medicine production method of the present invention is:
1, get Radix Notoginseng, Rhizoma Coptidis, Rhizoma Corydalis, Radix Et Rhizoma Rhei earlier and eliminate impurity after the weighing respectively, use ethanol extraction, remove residue, receive cream, oven dry, it is standby to be crushed to 120 orders;
2, get Pseudobulbus Bletillae (Rhizoma Bletillae) dry product and remove most impurity, be crushed to 120 orders after high-temperature sterilization standby;
3, get Concha Arcae and clean with clear water, eliminate residual meat and silt, it is standby to be crushed to 80 orders down after the calcining through 500-1000 ℃ of high temperature;
4, get Endoconcha Sepiae clean to remove impurity and be crushed to 120 orders after high-temperature sterilization standby;
5, above-mentioned powder is mixed and made into powder by proportioning, made various dosage forms behind the sterilization in 30 minutes through 110 ℃ of high temperature.
The present invention has following advantage through clinical use:
1, the selected multiple pure Chinese herbal medicine of the present invention, each component meet pharmaceutical control law regulation, utilize comprehensive function treatment gastritis, stomach, the duodenum illness of various Chinese herbal medicine, do not contain any chemical constituent, and be nontoxic and do not have any untoward reaction to human body.
2, the present invention need not to decoct, and can be made into various dosage forms (as making the capsule taking convenience) after the modernization process preparation method is extracted, and each dosage form all meets national drug health legislation regulation.
3, mechanism is original, good because the present invention cures the disease, so drug effect is long, and good effect, cure rate height, the extensive and treating both the principal and secondary aspects of a disease of indication.
4, medicine of the present invention has and regulates the flow of vital energy, and treating blood disorders helps the effect of transporting and transforming function of the spleen and stomach, to the also low dose of medication of prevention and health care of healthy elder crowd, both can strengthen digestive function, appetite stimulator, and the generation of preventable disease again really is " ill curing the disease, a no treating diseases and making health-care ".
The present invention's 300 routine clinical application experiments have fully proved above-mentioned superiority:
Select 150 gastritis (various) patient; 150 of stomach, duodenal ulcer patients, age 10-75 year, women 72 people among the gastritis sufferer, male 78 people; Women 63 people among the ulcer patient, male 87 people.
Method of administration: with capsule preparations oral administration of the present invention, every day, three each 1-2 grains serve on 7 days, then each 1 of every day three times, serve on 23 days, were a course of treatment with 30 days.
With capsule preparations of the present invention through a clinical total effective rate 83% of course of therapy gastritis group patient; Ulcer group patient is clinical always 89%.Alternative gastritis group model case 30 people (male 21 people, women 9 people); Ulcer group 30 people (male 19 people, women 11 people) carry out taking medicine of two courses of treatment, carry out after the drug withdrawal following up a case by regular visits in 3 years, and wherein gastritis group 18 people (male 11 people, women 7 people) did not have recurrence in 3 years, were considered as recovery from illness, and 8 people's disease cycle frequencies descend, the morbidity intensity decreases; Ulcer group 14 people (male 10 people, women 4 people) did not have recurrence in 3 years, were considered as recovery from illness, and 14 people's disease cycles descend, the morbidity intensity decreases.
The specific embodiment
Embodiment:
Take by weighing raw material (kilogram) by following proportioning
Radix Notoginseng 12.5 Rhizoma Coptidis 8 Pseudobulbus Bletillae (Rhizoma Bletillae)s 33.5 Rhizoma Corydalis 28
Radix Et Rhizoma Rhei 17 Concha Arcaes 22 Endoconcha Sepiaes 19
Production method is as follows:
Get Radix Notoginseng, Rhizoma Coptidis, Rhizoma Corydalis, Radix Et Rhizoma Rhei and eliminate impurity after the weighing respectively and remove residue, receive cream with ethanol extraction, oven dry, it is standby to be crushed to 120 orders; High-temperature sterilization is standby after getting the Pseudobulbus Bletillae (Rhizoma Bletillae) dry product and removing impurity and be crushed to 120 orders; Get Concha Arcae and clean with clear water, eliminate residual meat and silt, it is standby to be crushed to 80 orders down after the calcining through 700 ℃ of high temperature; Get Endoconcha Sepiae clean to remove impurity and be crushed to 120 orders after high-temperature sterilization standby.Above-mentioned several fine powder components are mixed in proportion the back 110 ℃ of following constant temperature 30 minutes, and then were cooled to 105 ℃ of constant temperature 10 minutes, reduce to again and make various dosage forms after 100 ℃ of constant temperature were sterilized in 10 minutes.
Claims (3)
1, a kind of medicine for the treatment of gastritis, stomach, duodenal ulcer is characterized in that it is the medicament of being made by the following weight proportion raw material
Radix Notoginseng 8-28 Rhizoma Coptidis 4-25 Pseudobulbus Bletillae (Rhizoma Bletillae) 10-40 Rhizoma Corydalis 15-50
Radix Et Rhizoma Rhei 8-45 Concha Arcae 15-30 Endoconcha Sepiae 8-25
2, the medicine of treatment gastritis according to claim 1, stomach, duodenal ulcer, wherein the weight proportion of each raw material is
Radix Notoginseng 11 Rhizoma Coptidis 8.5 Pseudobulbus Bletillae (Rhizoma Bletillae)s 35 Rhizoma Corydalis 29
Radix Et Rhizoma Rhei 14.5 Concha Arcaes 20.4 Endoconcha Sepiaes 17
3, a kind of preparation method for the treatment of the medicine of gastritis, stomach, duodenal ulcer is characterized in that getting earlier Radix Notoginseng, Rhizoma Coptidis, Rhizoma Corydalis, Radix Et Rhizoma Rhei and eliminates impurity after the weighing respectively, uses ethanol extraction, removes residue, receives cream, oven dry, and it is standby to be crushed to 120 orders; Get Pseudobulbus Bletillae (Rhizoma Bletillae) dry product and remove most impurity, be crushed to 120 orders after high-temperature sterilization standby; Get Concha Arcae and clean with clear water, eliminate residual meat and silt, it is standby to be crushed to 80 orders down after the calcining through 500-1000 ℃ of high temperature; Get Endoconcha Sepiae clean to remove impurity and be crushed to 120 orders after high-temperature sterilization standby; Above-mentioned powder is mixed and made into powder by proportioning, made various dosage forms behind the sterilization in 30 minutes through 110 ℃ of high temperature.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021380082A CN1177606C (en) | 2002-07-24 | 2002-07-24 | Medicine for treating gastritis and gastric or duodenal ulcer and its preparing process |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021380082A CN1177606C (en) | 2002-07-24 | 2002-07-24 | Medicine for treating gastritis and gastric or duodenal ulcer and its preparing process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1390600A true CN1390600A (en) | 2003-01-15 |
| CN1177606C CN1177606C (en) | 2004-12-01 |
Family
ID=4749231
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB021380082A Expired - Fee Related CN1177606C (en) | 2002-07-24 | 2002-07-24 | Medicine for treating gastritis and gastric or duodenal ulcer and its preparing process |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1177606C (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1330355C (en) * | 2005-06-02 | 2007-08-08 | 陈贤柱 | Chinese medicinal composition for treating ulcer |
| CN105288352A (en) * | 2015-10-23 | 2016-02-03 | 彭树林 | Medicine for treating gastric and duodenal ulcer and preparation technology |
| CN108310296A (en) * | 2018-04-23 | 2018-07-24 | 党东 | A kind of Solid oral pharmaceutical for treating stomach trouble |
| CN110038088A (en) * | 2019-05-10 | 2019-07-23 | 边稳利 | A kind of Traditional Chinese medicine liniment and preparation method thereof for treating gastric ulcer |
-
2002
- 2002-07-24 CN CNB021380082A patent/CN1177606C/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1330355C (en) * | 2005-06-02 | 2007-08-08 | 陈贤柱 | Chinese medicinal composition for treating ulcer |
| CN105288352A (en) * | 2015-10-23 | 2016-02-03 | 彭树林 | Medicine for treating gastric and duodenal ulcer and preparation technology |
| CN108310296A (en) * | 2018-04-23 | 2018-07-24 | 党东 | A kind of Solid oral pharmaceutical for treating stomach trouble |
| CN110038088A (en) * | 2019-05-10 | 2019-07-23 | 边稳利 | A kind of Traditional Chinese medicine liniment and preparation method thereof for treating gastric ulcer |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1177606C (en) | 2004-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102319350A (en) | External scald oil medicinal composition for treating burns and scalds | |
| CN100464778C (en) | Medicine for treating gastric ulcer and duodenal ulcer | |
| CN101297889B (en) | Chinese medicine preparation for treating foot-and-mouth disease and preparation method thereof | |
| CN100396315C (en) | Oral Chinese medicine for treating and preventing recurrence of uecerative stomatitis | |
| CN1931329A (en) | Stomatocase treating medicine | |
| CN102038829A (en) | Medicament for treating gastritis and ulcers of stomachs and duodenums | |
| CN102125678B (en) | Chinese medicinal preparation for treating hysteria disease | |
| CN1177606C (en) | Medicine for treating gastritis and gastric or duodenal ulcer and its preparing process | |
| CN104001131B (en) | A kind of Chinese medicine for oral administration preventing and treating stress ulcer | |
| CN103893613B (en) | A kind of medicine treating oral ulcer and preparation method | |
| CN1089594C (en) | Traditional Chinese medicine for curing psoriasis | |
| CN101979035A (en) | Medicament for treating gynecological abnormal leucorrhea | |
| CN101757465B (en) | Traditional Chinese medicine capsule for treating cervical spondylosis, lumbar disc herniation, cervicodynia and lumbodynia | |
| CN100402077C (en) | Medicinal composition for treating hyperosteogency | |
| CN102716448A (en) | Chinese patent medicine and TCM decoction capable of effectively curing nausea and vomiting | |
| CN100337681C (en) | Gastric ulcer treating medicine | |
| CN104547591A (en) | Pharmaceutical composition for treating acute ankle sprain | |
| CN1618439A (en) | Broad-specturm medicine for treating snake venom poisoning | |
| CN1277571C (en) | Chinese medicine preparation for stomach diseases | |
| CN103623335B (en) | A kind of Chinese medicine preparation for the treatment of rhinitis | |
| CN1141113C (en) | Chinese patent medicine for curing peptic ulcer | |
| CN1190593A (en) | Medicine for the treatment of rheumatism and arthritis | |
| CN1064844C (en) | Chinese medicine | |
| CN1245181C (en) | Chinese medicine of capsule (tablet) of nine ingredients for treating psoriasis and its preparing process | |
| CN103070998B (en) | Externally-applied plaster for curing pain of rheumatic joints |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20041201 Termination date: 20150724 |
|
| EXPY | Termination of patent right or utility model |